GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Days Payable

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Days Payable : 65.98 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Days Payable?

Hunan Er-Kang Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥140 Mil. Hunan Er-Kang Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥193 Mil. Hence, Hunan Er-Kang Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 65.98.

The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's Days Payable or its related term are showing as below:

SZSE:300267' s Days Payable Range Over the Past 10 Years
Min: 20.19   Med: 30.02   Max: 51.23
Current: 46.26

During the past 13 years, Hunan Er-Kang Pharmaceutical Co's highest Days Payable was 51.23. The lowest was 20.19. And the median was 30.02.

SZSE:300267's Days Payable is ranked worse than
77.1% of 974 companies
in the Drug Manufacturers industry
Industry Median: 87.765 vs SZSE:300267: 46.26

Hunan Er-Kang Pharmaceutical Co's Days Payable increased from Mar. 2023 (39.74) to Mar. 2024 (65.98). It may suggest that Hunan Er-Kang Pharmaceutical Co delayed paying its suppliers.


Hunan Er-Kang Pharmaceutical Co Days Payable Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Days Payable Chart

Hunan Er-Kang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.19 28.15 30.90 42.22 41.29

Hunan Er-Kang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.74 42.17 45.37 36.42 65.98

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Er-Kang Pharmaceutical Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Days Payable falls into.



Hunan Er-Kang Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hunan Er-Kang Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (198.705 + 122.299) / 2 ) / 1418.932*365
=160.502 / 1418.932*365
=41.29

Hunan Er-Kang Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (122.299 + 157.399) / 2 ) / 193.402*365 / 4
=139.849 / 193.402*365 / 4
=65.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Er-Kang Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description

Traded in Other Exchanges
N/A
Address
Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Headlines

No Headlines